Other languages Verve Therapeutics, Inc.

Equities

VERV

US92539P1012

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
6.16 ^USD	-0.96%		-7.23%	-55.81%

03/04	Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating	MT
02/04	Sector Update: Health Care Stocks Slide Late Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Slide Late Afternoon	03/04
Top Midday Decliners	02/04
Looming Factory Orders, Job Openings Data Prompt Lower Premarket Action for US Equity Futures	02/04
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday	02/04
Sector Update: Health Care	02/04
Verve Therapeutics Pauses Heart-1 Trial After Serious Adverse Events; Shares Fall Pre-Bell	02/04
Top Premarket Decliners	02/04
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels	02/04
Verve Therapeutics, Inc. Announces Updates on its PCSK9 Program	02/04
Verve Therapeutics Q4 Net Loss Widens, Collaboration Revenue Rises; Beats Estimates; Shares Rise	27/02
Verve Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Verve Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Google Ventures adds partner to back AI, open source startups	13/12
Sector Update: Health Care Stocks Advance Premarket Wednesday	29/11
Rate Outlooks Push Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday	29/11
Verve Therapeutics Prices $148 Million Common Stock Offering, Concurrent Private Placement; Shares Slump Pre-Bell	29/11
Verve Therapeutics Prices Offering of Common Shares, Concurrent Private Placement for Proceeds of $148 Million	29/11
Verve Therapeutics Proposes Common Stock Public Offering, Concurrent Private Placement -- Shares Slump After Hours	29/11
Top Midday Decliners	14/11
Sector Update: Health Care Stocks Mixed Pre-Bell Monday	13/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Verve Therapeutics, Inc.

Equities

VERV

US92539P1012

Other languages

Filters